Patents by Inventor Gerard Jaouen

Gerard Jaouen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9758541
    Abstract: The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof, a stereoisomer or a mixture of stereoisomers in any ratio, or a water-soluble derivative, as well as to methods for preparing same and to the use thereof, in particular in the treatment of cancer.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: September 12, 2017
    Assignee: PARIS SCIENCES ET LETTRES—QUARTIER LATIN
    Inventors: Gerard Jaouen, Pascal Pigeon, Siden Top
  • Publication number: 20170166600
    Abstract: The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof, a stereoisomer or a mixture of stereoisomers in any ratio, or a water-soluble derivative, as well as to methods for preparing same and to the use thereof, in particular in the treatment of cancer.
    Type: Application
    Filed: October 30, 2014
    Publication date: June 15, 2017
    Inventors: Gerard Jaouen, Pascal Pigeon, Siden Top
  • Patent number: 8426462
    Abstract: The present invention relates to compounds of the following formula (I): and to the pharmaceutically acceptable salts thereof, to the isomers and the mixtures of isomers thereof and to the water-soluble derivatives thereof, as well as to the method for preparing same and to the use thereof, particularly in the treatment of cancer.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: April 23, 2013
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Gérard Jaouen, Anne Vessieres-Jaouen, Damian Plazuk
  • Publication number: 20110190391
    Abstract: The present invention relates to compounds of the following formula (I): and to the pharmaceutically acceptable salts thereof, to the isomers and the mixtures of isomers thereof and to the water-soluble derivatives thereof, as well as to the method for preparing same and to the use thereof, particularly in the treatment of cancer.
    Type: Application
    Filed: July 2, 2009
    Publication date: August 4, 2011
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Gérard Jaouen, Anne Vessieres-Jaouen, Damian Plazuk
  • Patent number: 5863911
    Abstract: Diarylethylene metallocene derivatives, processes for preparing the same and pharmaceutical compositions which contain the derivatives are disclosed. The compounds of the invention can exhibit anti-tumor activity, and can be particularly useful in the treatment of estrogen-dependent cancers.
    Type: Grant
    Filed: August 11, 1997
    Date of Patent: January 26, 1999
    Assignee: Modelisation et Mise au Point de Molecules Medicinales
    Inventors: Gerard Jaouen, Siden Top
  • Patent number: 4983646
    Abstract: The present invention relates to an estrogen complex which consists of an estrogen or an estrogen derivative complexed with an organometallic compound containing at least one free carbonyl ligand, the said estrogen complex containing at least one free hydroxyl radical and no free phenolic hydroxyl radical in the .alpha.-position to the site where the organometallic compound is attached.The complexes according to the invention are useful for the determination of hormone receptors.
    Type: Grant
    Filed: July 24, 1988
    Date of Patent: January 8, 1991
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Gerard Jaouen, Anne Vessieres, Siden Top
  • Patent number: 4656142
    Abstract: The present invention relates to an estrogen complex which consists of an estrogen or an estrogen derivative complexed with an organometallic compound containing at least one free carbonyl ligand, the said estrogen complex containing at least one free hydroxyl radical and no free phenolic hydroxyl radical in the .alpha.-position to the site where the organometallic compound is attached.The complexes according to the invention are useful for the determination of hormone receptors.
    Type: Grant
    Filed: September 20, 1983
    Date of Patent: April 7, 1987
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Gerard Jaouen, Anne Vessieres, Siden Top